Browsing by Contributors Oldgren, Jonas

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 13 of 13
PreviewIssue DateTitleContributor(s)
2018 EHJ Volume 39 Issue 16 April (19).pdf.jpg2018The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillationSteffel, Jan; Verhamme, Peter; Potpara, Tatjana S; Albaladejo, Pierre; Antz, Matthias; Desteghe, Lien; Haeusler, Karl Georg; Oldgren, Jonas; Reinecke, Holger; Roldan-schilling, Vanessa; Rowell, Nigel; Sinnaeve, Peter; Collins, Ronan; Camm, A John; Heidbu, Hein; Eickels,
EuroPace 2018 Volume 20 Issue 8 August (22).pdf.jpg2018The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation : executive summarySteffel, Jan; Verhamme, Peter; Potpara, Tatjana S; Albaladejo, Pierre; Antz, Matthias; Desteghe, Lien; Haeusler, Karl Georg; Oldgren, Jonas; Reinecke, Holger; Roldan-schilling, Vanessa; Rowell, Nigel; Sinnaeve, Peter; Collins, Ronan; Camm, A John; Heidbu, Hein; Eickels,
2016 EHJ Volume 37 Issue 20 May (5).pdf.jpg2016The ABC ( age , biomarkers , clinical history ) stroke risk score : a biomarker-based risk score for predicting stroke in atrial fibrillationAlexander, John H; Hanna, Michael; Held, Claes; Hijazi, Ziad; Lindba, Johan; Hylek, Elaine M; Lopes, Renato D; Oldgren, Jonas; Siegbahn, Agneta; Stewart, Ralph A H; White, Harvey D; Granger, Christopher B; Wallentin, Lars; Investigators, Stability
EHJ 2018 Volume 39 Issue 32 August (3).pdf.jpg2018Apixaban compared to heparin / vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion : the EMANATE trialEzekowitz, Michael D; Jr, Charles V Pollack; Halperin, Jonathan L; England, Richard D; Nguyen, Sandra Vanpelt; Spahr, Judith; Sudworth, Maria; Cater, Nilo B; Breazna, Andrei; Oldgren, Jonas; Kirchhof, Paulus
2018 EHJ Volume 39 Issue 6 February (5).pdf.jpg2018Atrial fibrillation A biomarker-based risk score to predict death in patients with atrial fibrillation : the ABC ( age , biomarkers , clinical history ) death risk scoreHijazi, Ziad; Oldgren, Jonas; Lindba, Johan; Alexander, John H; Connolly, Stuart J; Eikelboom, John W; Ezekowitz, Michael D; Held, Claes; Hylek, Elaine M; Lopes, Renato D; Yusuf, Salim; Granger, Christopher B; Siegbahn, Agneta; Wallentin, Lars
2017 AHJ Volume 190 August (16).pdf.jpg2017Growth-differentiation factor 15 and risk of major bleeding in atrial fibrillation: Insights from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trialHijazi, Ziad; Oldgren, Jonas; Andersson, Ulrika; Connolly, Stuart J.; Eikelboom, John W.; Ezekowitz, Michael D.; Reilly, Paul a.; Yusuf, Salim; Siegbahn, Agneta; Wallentin, Lars
2016 EEJEP Volume 18 Issue 7 July (5).pdf.jpg2016Long-term evaluation of dabigatran 150 vs . 110 mg twice a day in patients with non-valvular atrial fibrillationEzekowitz, Michael D; Eikelboom, John; Oldgren, Jonas; Reilly, Paul A; Brueckmann, Martina; Kent, Anthony P; Pogue, Janice; Spahr, Judith; Clemens, Andreas; Noack, Herbert; Diener, Hans-christoph; Wallentin, Lars; Yusuf, Salim; Connolly, Stuart J
2016 Lancet Volume 387 Issue 10035 June (4).pdf.jpg2016The novel biomarker-based ABC ( age , biomarkers , clinical history ) -bleeding risk score for patients with atrial fi brillation : a derivation and validation studyHijazi, Ziad; Oldgren, Jonas; Lindbäck, Johan; Alexander, John H; Connolly, Stuart J; Eikelboom, John W; Ezekowitz, Michael D; Held, Claes; Hylek, Elaine M
2016 LANCET Volume 388 Issue 10050 September (5).pdf.jpg2016Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fi brillation : a cohort studyHealey, Jeff S; Oldgren, Jonas; Ezekowitz, Michael; Zhu, Jun; Pais, Prem; Wang, Jia; Commerford, Patrick; Jansky, Petr; Avezum, Alvaro; Sigamani, Alben; Town, Cape; Town, Cape
2018 EHJ Volume 38 Issue 19 May (12).pdf.jpg2018Safety and efficacy of dual vs . triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention : a systematic review and meta-analysis of randomized clinical trialsGolwala, Harsh B; Cannon, Christopher P; Steg, Ph Gabriel; Doros, Gheorghe; Qamar, Arman; Ellis, Stephen G; Oldgren, Jonas; Berg, Jurrien M; Kimura, Takeshi; Hohnloser, Stefan H; Lip, Gregory Y H; Bhatt, Deepak L
2017 Europace Volume 19 Issue 10 October (24).pdf.jpg2017Short-term dabigatran interruption before cardiac rhythm device implantation : multi- centre experience from the RE-LY trialEssebag, Vidal; Proietti, Riccardo; Birnie, David H; Wang, Jia; Douketis, James; Coutu, Benoit; Parkash, Ratika; Lip, Gregory Y H; Hohnloser, Stefan H; Moriarty, Andrew; Oldgren, Jonas; Connolly, Stuart J; Ezekowitz, Michael; Healey, Jeff S
1467.full.pdf.jpgOct-2015Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillationHeidbuchel, Hein; Verhamme, Peter; Alings, Marco; Antz, Matthias; Diener, Hans-Christoph; Hacke, Werner; Oldgren, Jonas; Sinnaeve, Peter; Camm, A John; Kirchhof, Paulus
2017 EuropeanHJ Volume 38 Issue 27 July (17).pdf.jpg2017Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation : Executive summaryHeidbuchel, Hein; Verhamme, Peter; Alings, Marco; Antz, Matthias; Diener, Hans-christoph; Hacke, Werner; Oldgren, Jonas; Sinnaeve, Peter; Camm, A John; Kirchhof, Paulus; Ahmad, Advisors Azhar; Pharma, M D Boehringer-ingelheim; Heinrich-nols, Jutta; Pharma, M D Boehrin